FIELD: medicine. SUBSTANCE: method involves determining the number of rosette- forming cells in leacadin presence in blood of a patient being in prolonged clinical remission state. Stimulated cells index being equal to 77.0- 59.0%, beginning disease generalization stage is predicted and chemo- hormone therapy is restarted. The stimulated cells index being equal to 58.0-40.0%, disease remission is predicted and chemotherapy is to be applied later in the following period. EFFECT: enhanced effectiveness in determining optimum time for restarting chemo-hormone therapy. 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR FORECASTING THERAPY EFFICIENCY AS APPLIED TO PATIENTS WITH CARCINOMA OF OVARY | 0 |
|
SU1805393A1 |
| METHOD OF ESTIMATION OF IMMUNE STATUS DAMAGE IN ONCOLOGICAL PATIENTS | 0 |
|
SU1820330A1 |
| METHOD OF PROGNOSIS OF DISEASE COURSE IN PATIENTS WITH UTERINE BODY CANCER | 2008 |
|
RU2395097C1 |
| METHOD FOR TREATING THE CASES OF OVARIAN CARCINOMA | 2001 |
|
RU2191586C1 |
| METHOD OF ESTIMATION OF INDIVIDUAL PATIENT SENSITIVITY WITH OVARY CANCER OF 3-4 DEGREE TO CHEMOHORMONE THERAPY | 0 |
|
SU1827639A1 |
| METHOD FOR PREDICTION OF RECURRENT CARCINOMA OF VULVA | 2013 |
|
RU2532342C1 |
| METHOD OF PREDICTING EFFICIENCY OF NEOADJUVANT CHEMOTHERAPY IN CASE OF LOCALLY ADVANCED OVARIAN CARCINOMA | 2008 |
|
RU2383339C1 |
| METHOD FOR PREDICTING THE PROGRESSION OF CERVICAL CANCER IN PATIENTS WITH STAGE IIB | 2022 |
|
RU2789500C1 |
| METHOD FOR TREATING THE CASES OF DISSEMINATED OVARIAN CARCINOMA | 2005 |
|
RU2283107C1 |
| METHOD OF FORECASTING OF EFFECTIVE PROCREATION RESTORATION AFTER IMMUNOCYTOTHERAPY FOR WOMEN SUFFERING FROM MISCARRIAGE AT EARLY STAGES | 2006 |
|
RU2329504C2 |
